Physician profile
John Stuart Blankenship
NPI 1225267370
$1,758.73
in general payments reported to CMS, 2019-2025
18 companies · $264 in 2025
The $264 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $707 · 2020: $203 · 2021: $210 · 2022: $158 · 2023: $36.65 · 2024: $181 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $390 · Education: $91.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $390.13 |
| Education | $91.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $395.19 | 2019-2021 | |
| Stryker Corporation | $366.13 | 2019-2025 | Iconix |
| Zimmer Biomet Holdings, INC. | $335.64 | 2019-2024 | Avenir |
| Pacira Pharmaceuticals Incorporated | $188.46 | 2021-2025 | Zilretta, Iovera, Exparel |
| Smith+Nephew, INC. | $100.50 | 2019-2025 | Pico 7, Pico 14, Renasys Touch |
| Vertex Pharmaceuticals Incorporated | $79.43 | 2025 | |
| Orthofix Medical, INC. | $65.26 | 2019-2023 | Physio-Stim |
| Depuy Synthes Sales INC. | $44.70 | 2019-2024 | Monovisc |
| Wound Management Technologies, INC | $27.73 | 2019 | |
| Innovation Technologies INC | $27.00 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $23.31 | 2023 | |
| Djo, LLC | $20.70 | 2019 | |
| Sanofi-Aventis U.S. LLC | $17.70 | 2020 | |
| Orthogenrx INC. | $16.64 | 2019 | |
| Kci USA, INC. | $14.13 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dynasplint Systems INC. | $12.86 | 2019 | |
| Convatec INC. | $11.86 | 2020 | |
| Baudax Bio INC. | $11.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Blankenship listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.